BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2759840)

  • 1. Cyclosporin-A treatment for early insulin-dependent diabetes mellitus: first experience in Israel.
    Kisch ES; Yust I
    Isr J Med Sci; 1989 Jul; 25(7):414-6. PubMed ID: 2759840
    [No Abstract]   [Full Text] [Related]  

  • 2. Cyclosporine trials in diabetes: updated results of the French experience.
    Assan R; Feutren G; Sirmai J
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):178-83. PubMed ID: 3289203
    [No Abstract]   [Full Text] [Related]  

  • 3. Functional consequences and risk factors of chronic cyclosporine nephrotoxicity in type I diabetes trials.
    Feutren G
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):356-66. PubMed ID: 3381298
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of immunosuppression with cyclosporine in insulin-dependent diabetes mellitus of recent onset: the Canadian open study at 44 months.
    Dupré J; Stiller CR; Gent M; Donner A; von Graffenreid B; Murphy G; Heinrichs D; Jenner MR; Keown PA; Laupacis A
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):184-92. PubMed ID: 3289204
    [No Abstract]   [Full Text] [Related]  

  • 5. [On C-peptide and some other parameters in children with insulin dependent diabetes mellitus (author's transl)].
    Koepp P; Kühnau J
    Monatsschr Kinderheilkd; 1982 Apr; 130(4):215-7. PubMed ID: 7048078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunosuppression in autoimmune disease: the double-edged sword.
    Jaworski MA; Jewell LD; Honore L; Mehta JG; Bayens-Simmonds J; McGuire-Clark P; Schouls JJ; Yap WY
    Clin Invest Med; 1987 Sep; 10(5):488-95. PubMed ID: 3315371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Efficacy of cyclosporin A (CsA) in insulin-dependent diabetes in children and analysis of the secondary effects].
    Lévy-Marchal C; Tubiana-Rufi N; Czernichow P
    Journ Annu Diabetol Hotel Dieu; 1987; ():187-97. PubMed ID: 3613364
    [No Abstract]   [Full Text] [Related]  

  • 8. [Results of an experimental animal controlled long-term study of cyclosporin A in diabetes mellitus type 1].
    Gardell C; Gardell D
    Beitr Infusionther Klin Ernahr; 1987; 18():393-5. PubMed ID: 3440000
    [No Abstract]   [Full Text] [Related]  

  • 9. [Cyclosporin as treatment for insulin dependent diabetes mellitus].
    Yust I; Merdler S; Kisch E
    Harefuah; 1988 Jan; 114(2):93-4. PubMed ID: 3350421
    [No Abstract]   [Full Text] [Related]  

  • 10. Cyclosporine, in combination with other drugs, studied in insulin-dependent diabetes therapy.
    Raymond CA
    JAMA; 1988 Mar; 259(11):1609, 1613-4. PubMed ID: 3343762
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical trials of cyclosporin in IDDM.
    Dupré J; Stiller CR; Gent M; Donner A; von Graffenried B; Heinrichs D; Jenner M; Keown P; Mahon J; Martell R
    Diabetes Care; 1988; 11 Suppl 1():37-44. PubMed ID: 3069390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetes, cyclosporin nephrotoxicity, and serum creatinine concentration.
    McNally PG; Feehally J; Walls J
    Diabet Med; 1991 Apr; 8(3):289. PubMed ID: 1828751
    [No Abstract]   [Full Text] [Related]  

  • 13. Cyclosporine for treatment of early type I diabetes: preliminary results.
    Stiller CR; Laupacis A; Dupre J; Jenner MR; Keown PA; Rodger W; Wolfe BM
    N Engl J Med; 1983 May; 308(20):1226-7. PubMed ID: 6341839
    [No Abstract]   [Full Text] [Related]  

  • 14. Cyclosporin in diabetes.
    Koivisto VA; Pelkonen R
    Lancet; 1985 Feb; 1(8425):401. PubMed ID: 2857455
    [No Abstract]   [Full Text] [Related]  

  • 15. Factors predictive of cyclosporine-induced nephrotoxicity: the role of cyclosporine blood levels.
    Bach JF; Feutren G; Noel LH; Hannedouche T; Landais P; Timsit J; Boitard C; Bougnères P; Boitard C; Grünfeld JP
    Transplant Proc; 1990 Jun; 22(3):1296-8. PubMed ID: 2349690
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of two periods with intensified insulin treatment on B-cell function during the first 18 months of type 1 (insulin-dependent) diabetes mellitus.
    Krarup T; Madsbad S
    Diabete Metab; 1986 Oct; 12(5):256-60. PubMed ID: 3542618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Limited duration of remission of insulin dependency in children with recent overt type I diabetes treated with low-dose cyclosporin.
    Bougnères PF; Landais P; Boisson C; Carel JC; Frament N; Boitard C; Chaussain JL; Bach JF
    Diabetes; 1990 Oct; 39(10):1264-72. PubMed ID: 2210078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The pancreatic reserve in diabetes mellitus by the determination of serum C-peptide using radioimmunoassay].
    Arteaga A; Velasco N; Szegedi AM; Pellegrino MR; López G; Foradori A; Acosta AM
    Rev Med Chil; 1984 Apr; 112(4):321-9. PubMed ID: 6385178
    [No Abstract]   [Full Text] [Related]  

  • 19. The role of C-peptide in the classification of diabetes mellitus.
    Wright-Pascoe R; Mills J; Choo-Kang E; Morrison EY
    West Indian Med J; 2000 Jun; 49(2):138-42. PubMed ID: 10948853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cyclosporin A and diabetes type I].
    Timsit J; Boitard C; Warnet A
    Rev Infirm; 1988 Feb; 38(3):27-30. PubMed ID: 3153531
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.